Please Wait
Applying Filters...
menu
    • menu
    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    SPI Pharma has been solving formulation challenges using superior functional materials.

    Virtual Booth

    Contact Supplier

    Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

    Virtual Booth

    Contact Supplier

    Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

    Virtual Booth

    Contact Supplier

    FAMAR CDMO- From early development to commercial manufacturing.

    Virtual Booth

    Contact Supplier

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Virtual Booth

    Contact Supplier

    Menu

    Valganciclovir Hydrochloride

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    ANALYTICAL

    PharmaCompass
    $ API Ref.Price (USD/KG) : 1,717Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Gpp Generic Valganciclovir Hydrochloride Receives Approval in US
    Gpp Generic Valganciclovir Hydrochloride Receives Approval in US

    11 Jun 2024

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212876

    FDA
    11 Jun 2024
    Share Share
    Aurobindo's Generic Valganciclovir Hydrochloride Receives Approval in the U.S.
    Aurobindo's Generic Valganciclovir Hydrochloride Receives Approval in the U.S.

    17 Nov 2022

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215124

    FDA
    17 Nov 2022
    Share Share
    Hetero's Generic Valganciclovir Hydrochloride Receives Approval in the U.S.
    Hetero's Generic Valganciclovir Hydrochloride Receives Approval in the U.S.

    04 Oct 2022

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211475

    FDA
    04 Oct 2022
    Share Share
    Valganciclovir leads to low blood counts in kidney transplant recipients
    Valganciclovir leads to low blood counts in kidney transplant recipients

    22 Feb 2022

    // PHARMABIZ

    http://www.pharmabiz.com/NewsDetails.aspx?aid=146017&sid=2

    PHARMABIZ
    22 Feb 2022
    Share Share
    Airis Pharma's Generic Valganciclovir Hydrochloride Receives Approval in U.S.
    Airis Pharma's Generic Valganciclovir Hydrochloride Receives Approval in U.S.

    17 Feb 2022

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210169

    FDA
    17 Feb 2022
    Share Share
    Takeda’s LIVTENCITY Available for Certain Individuals Ages 12 Years and Older
    Takeda’s LIVTENCITY Available for Certain Individuals Ages 12 Years and Older

    02 Dec 2021

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20211202005653/en

    BUSINESSWIRE
    02 Dec 2021
    Share Share